Is insulin the most effective injectable antihyperglycaemic therapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is insulin the most effective injectable antihyperglycaemic therapy?

Published:2014-11-09 Issue:2 Volume:17 Page:145-151
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Buse J. B.¹,Peters A.²,Russell‐Jones D.³,Furber S.⁴,Donsmark M.⁵,Han J.⁶,MacConell L.⁶,Maggs D.⁶,Diamant M.⁷

Affiliation:

1. University of North Carolina School of Medicine Medicine/Endocrinology Chapel Hill NC USA

2. Keck School of Medicine University of Southern California Los Angeles CA USA

3. Endocrinology and Metabolism, Royal Surrey County Hospital Guildford UK

4. Novo Nordisk Pharmaceuticals Sydney Australia

5. Novo Nordisk A/S Søborg Denmark

6. Amylin Pharmaceuticals LLC San Diego CA USA

7. VU University Medical Center Diabetes Center, Department of Internal Medicine Amsterdam The Netherlands

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12402

Reference12 articles.

1. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2. Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

3. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

4. Issues for stratified randomization based on a factor derived from a continuous baseline variable

5. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The entero-insular axis and metabolic syndrome;Metabolic Syndrome;2024

2. Barriers and facilitators to insulin treatment: a phenomenological inquiry;Journal of Pharmaceutical Policy and Practice;2022-07-19

3. Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label trial study;Journal of Diabetes Investigation;2022-02-08

4. Comparing Real-World Effectiveness of Dulaglutide and Insulin as the First Injectable for Patients with Type 2 Diabetes: An Australian Single-Site Retrospective Chart Review;Diabetes Therapy;2021-11-30

5. Pharmacological Management of Diabetes for Reducing Glucose Levels and Cardiovascular Disease Risk: What Evidence in South Asians?;Current Diabetes Reviews;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3